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ABSTRACT: Oxycodone is a strong opioid frequently used as an analgesic. Although proven efficacious in the manage-
ment of moderate to severe acute pain and cancer pain, the use of oxycodone imposes a risk of adverse effects such as 
addiction, overdose, and death. Fast and accurate determination of oxycodone blood concentration would enable person-
alized dosing and monitoring of the analgesic as well as quick diagnostics of possible overdose in emergency care. How-
ever, in addition to the parent drug, several metabolites are always present in the blood after a dose of oxycodone and, as 
of today, there is no electrochemical data available on any of these metabolites. In this paper, a single-walled carbon 
nanotube (SWCNT) electrode and a Nafion-coated SWCNT electrode were used, for the first time, to study the electro-
chemical behavior of oxycodone and its two main metabolites, noroxycodone and oxymorphone. Both electrode types 
could selectively detect oxycodone in the presence of noroxycodone and oxymorphone. However, we have previously 
shown that the addition of Nafion coating on top of the SWCNT electrode is essential for direct measurements in com-
plex biological matrices. Thus, the Nafion/SWCNT electrode was further characterized and used for measuring clinically 
relevant concentrations of oxycodone in buffer solution. The limit of detection for oxycodone with the Nafion/SWCNT 
sensor was 85 nM and the linear range 0.5 - 10 µM in buffer solution. This study shows that the fabricated Nafion/SWCNT 
sensor has potential to be applied in clinical concentration measurements. 
1. Introduction 
Oxycodone is a strong opioid widely used as an analgesic. 
As with all opioids, oxycodone can cause severe adverse 
effects such as addiction, overdose, and death due to res-
piratory depression. In 2017, more than 70 000 drug over-
dose deaths occurred in the Unites States alone, 68% of 
which involved opioids, including oxycodone1. The phar-
macokinetic profile of oxycodone is affected by several 
factors such as age, sex, concomitant diseases, and drug-
drug interactions2. In addition, the plasma concentrations 
of oxycodone leading to sufficient analgesia after surgery 
are highly individual, the average concentrations ranging 
between 0.3 nM and 100 nM3 and in cases of overdose, the 
highest concentrations found in blood can be over 10 µM4. 
Thus, there is need for a fast and accurate method to as-
sess the blood concentrations of oxycodone to support 
safe and efficacious pain management and enable rapid 




Figure 1. The chemical structures and metabolic pathways of oxycodone and its oxidative metabolites. The percentages in the 
colored diagrams show the peak plasma concentrations (Cmax) (mol/L) of noroxycodone, noroxymorphone and oxymorphone 
relative to the peak plasma concentration of oxycodone. These concentrations have been measured in human plasma after a 
single dose of oxycodone5.  The arrows represent the metabolic pathways leading to the oxidation of the molecules by the CYP3A 
or CYP2D6 enzymes. 
The chemical structures and metabolic pathways of ox-
ycodone and its oxidative metabolites are shown in Fig. 1. 
In addition to the parent drug oxycodone, there are al-
ways various metabolites present in the blood after sys-
temic administration. Oxycodone undergoes extensive 
oxidative metabolism by hepatic cytochrome P 450 (CYP) 
enzymes2,5. Oxycodone is mainly oxidized into noroxyco-
done by CYP3A enzymes and, to a lesser extent, to oxy-
morphone by CYP2D6. From these two, the major metab-
olite noroxycodone can reach high blood concentrations 
but has low affinity to the µ-opioid receptor and thus, 
does not contribute to oxycodone analgesia6,7. Similarly, 
oxymorphone has no significant role in the overall opioid 
effect of oxycodone due to very low plasma concentra-
tions achieved after oxycodone administration5. However, 
oxymorphone has higher activity at the µ-opioid receptor 
than the parent drug and it is also used as an analgesic by 
itself6,7.  
Both noroxycodone and oxymorphone are further oxi-
datively metabolized to noroxymorphone by CYP2D6 and 
CYP3A, respectively (Fig. 1). Noroxymorphone can reach 
relatively high concentrations in plasma after oral admin-
istration of oxycodone, but has no analgesic effect due to 
poor penetrance through the blood-brain barrier5,8. In 
addition to the oxidative metabolites, oxycodone has sev-
eral reductive metabolites. However, the main pharmaco-
logic effect of oxycodone seems to be attributed to the 
parent drug alone5.  
The gold standard method for measuring plasma con-
centrations of oxycodone and other opioids is high-
performance liquid chromatography (HPLC) often cou-
pled with mass spectrometry3,9,10, a method already used 
for decades11. This method provides extreme specificity 
and low limits of quantification, but the measurements 
are time consuming, laborious and require skilled labora-
tory personnel. While point-of-care drug concentration 
measurements would often aid in clinical decision-
making, performing a HPLC analysis takes up to a few 
hours. Electrochemical methods have been shown to pro-
vide fast response time, high sensitivity and simple usabil-
ity in sensor applications. They have also been used to 
measure opioid concentrations12–17. However, only a few 
studies on electrochemical detection of oxycodone have 
been published12 and, to our knowledge, there are cur-
rently no reported studies on electrochemical behavior of 
oxycodone together with its main metabolites. 
Carbon nanomaterials, including single-walled carbon 
nanotubes (SWCNT), have been widely used in electro-
chemical sensor applications due to their high conductivi-
ty, biocompatibility, good sensitivity and fast response 
time18. A considerable advantage of the SWCNT networks, 
specifically, is their compatibility with industrial manu-
facturing processes, making them a desirable material for 
large scale production of, e.g., disposable sensor strips. In 
addition, SWCNTs can be functionalized or otherwise 
tuned for specific applications for example by selecting 
appropriate catalysts for the fabrication19. In our previous 
studies, we have also shown that the performance of a 
sensor can be further improved by combining the excep-
tional qualities of carbon nanomaterials with the selective 
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properties of the ion-exchange membrane Nafion15,16,20. 
The Nafion membrane contains nanosized interconnected 
hydrophilic channels coated with negatively charged sul-
fonic groups and thus only allows cationic molecules, 
including opioids, through while practically blocking ani-
ons from the electrode surface. This is a particularly ad-
vantageous property for electrochemical sensors applied 
in biological matrices, since many of the interfering mole-
cules, such as ascorbic acid and uric acid, are in anionic 
form at the physiological pH. Thus, coating the electrode 
with a Nafion membrane not only increases the selectivity 
of the electrode but also enables detection of analytes in 
complex biological matrices.  
In this work, we investigated the use of a plain SWCNT 
electrode as well as a SWCNT electrode coated with a thin 
Nafion layer for selective detection of oxycodone in the 
presence of its two metabolites noroxycodone and oxy-
morphone. These metabolites were selected based on 
their high relative concentration (noroxycodone), analge-
sic activity (oxymorphone) and availability. Differential 
pulse voltammetry (DPV) was selected for the appropriate 
electrochemical method, since it provides a low signal-to-
noise ratio and a response time of just a few minutes. The 
electrochemical behavior of oxycodone, noroxycodone 
and oxymorphone was studied on both plain and Nafion 
coated SWCNT electrodes. Due to its better applicability 
in real clinical samples15,16, the Nafion/SWCNT electrode 
was further characterized and applied in measuring clini-
cally relevant concentrations of oxycodone in buffer solu-
tion. Both electrode types were then shown to be able to 
detect oxycodone in the presence of its two main metabo-
lites, while the Nafion coating slightly improved the sen-
sitivity towards oxycodone. These results show that the 
SWCNT/Nafion has potential to be applied in further 
studies for selective detection of oxycodone in clinical 
concentration measurements. 
2. Materials and methods 
2.1. Preparation of Nafion/SWCNT electrode 
The SWCNT networks were synthesized by aerosol 
chemical vapor deposition (CVD), using the process de-
scribed in more detail in21,22. Briefly, in this thermal high 
temperature floating catalyst CVD, iron nanoparticles are 
first produced in a carbon monoxide atmosphere in a 
laminar flow reactor. In these conditions, the formed iron 
acts as a catalyst to decompose the carbon monoxide, 
leading to nucleation and growth of SWCNTs. The 
SWCNTs are collected onto a membrane filter resulting in 
a sheet of SWCNT network.  
A piece of the received SWCNT network was cut from 
the filter paper and press transferred by hand onto a glass 
slide (Thermo Scientific, ISO 8037-1) with dimensions of 1 
x 2 cm. The glass slide was pre-cleaned by immersing in 
acetone (AnalaR NOMRAPUR, Merck) and ethanol (99.5 
wt-%, Altia, Finland). After press transferring, the filter 
paper was removed, and the network densified with a 
drop of ethanol which was allowed to dry at room tem-
perature. Silver contact pads were painted with conduc-
tive silver paint (Electrolube) and allowed to dry for at 
least one hour. A piece of conductive copper tape (Ted 
Pella, Inc.) was placed at the end of the contact pad to 
enable a robust connection point for the electrode leads.  
Finally, the electrode was covered with polytetrafluoro-
ethylene film (PTFE, Saint-Gobain Performance Plastics 
CHR 2255-2) with a 3-mm hole to isolate the working 
electrode area and to attach the SWCNT network onto 
the glass substrate. The film was allowed to adhere to the 
glass surface overnight. The following day, the electrode 
was coated with 2.5 wt-% Nafion, diluted from 5 wt-% 
Nafion D-520 solution (Alfa Aesar) with 94 wt-% ethanol 
(Altia, Finland). The coating was done with a mechanical 
dip-coater by immersing the electrode into the solution 
for 5 seconds and allowed to dry for 30 seconds before 
detaching from the holder. The prepared electrode was 
dried in ambient air overnight before the measurements. 
2.2. Electrochemistry equipment and measurement pa-
rameters 
All electrochemical measurements were done with a 
three-electrode system with a CH Instrument (CHI630E) 
potentiostat. Ag/AgCl (+0.199 V vs standard hydrogen 
electrode, Radiometer Analytical) was used as a reference 
and platinum wire as the counter electrode. The potential 
window was from -0.4 V to 1.3 V, pulse amplitude 50 mV, 
step potential 4 mV and pulse period 0.2 s. Phosphate 
buffered saline (PBS 0.01 M, pH 7.4) was used as the elec-
trolyte. All solutions were purged with N2 for at least 10 
min prior to the measurements and deoxygenation was 
continued throughout the measurements. 
The prepared Nafion/SWCNT electrodes were always 
measured the following day after Nafion coating if not 
stated otherwise. Before starting the measurements, the 
electrodes were allowed to swell in phosphate buffered 
saline PBS for 30 min. Background signals were collected 
with DPV at least five times or until the stability of the 
background was satisfactory so that two consecutive 
backgrounds were overlapping. An additional background 
with 5 min accumulation time was measured if an accu-
mulation time was applied in the analyte measurements 
as well. In the OXC concentration series measurements, 
to improve background stability the samples were cycled 
approximately 20 times with DPV in PBS solution. In ad-
dition, three consecutive backgrounds with 5 min accu-
mulation time were recorded for determining the values 
for the limit of detection (LOD), keeping the electrodes in 
PBS for 5 min between each measurement. In general, a 5 
min accumulation time was used in all measurements 
unless stated otherwise. All measurements were repeated 
with at least three electrodes. 
2.3. Characterization of SWCNT network 
The physical and chemical structure of the SWCNT 
network was characterized with transmission electron 
microscopy (TEM) and X-ray absorption spectroscopy 
(XAS). The samples for TEM imaging were prepared by 
press transferring a piece of the SWCNT network on a 
S147AH Au TEM grid with holey carbon films (Agar Scien-
tific). The analysis was conducted with a double aberra-
tion-corrected electron microscope JEOL 2200FS (JEOL, 
Japan) with a Gatan 4k×4kUltraScan 4000 CCD camera 
for the digital recording of the high resolution TEM 
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(HRTEM) images. The microscope was operated at 200 
kV with a field-emission electron gun. 
For the XAS analysis, SWCNT samples were similarly 
prepared on a highly conductive (<0.005 Ωcm-1) boron 
doped Si <100> wafer (Sieger Wafer, Germany). The spec-
tra were recorded at the Stanford Synchrotron Radiation 
Lightsource (SSRL) according to the protocol described in 
more detail in17. The X-ray energies used for the Carbon 
(C1s), Oxygen (O1s) and Iron (Fe2p) were 260 eV to 350 
eV, 520 eV to 580 eV and 695 eV to 735 eV, respectively. 
Total electron yield (TEY) mode was used for the data 
collection, the drain current being amplified by a Keithley 
picoammeter. For determining the sheet resistance of the 
SWCNT network, four-point probe measurements were 
carried out on a Hewlett Packard 3458A multimeter at-
tached to a Jandel RM3000 multi-height probe. 
2.4. Characterization of Nafion/SWCNT electrodes 
The concentration of the Nafion solution to be used for 
coating was determined by comparing the performance of 
2.5% and 5% Nafion. SWCNT electrodes were coated with 
both concentrations and measured in 5 µM OXC in PBS 
with DPV. The thickness of the Nafion coatings were 
measured with a contact profilometer (Dektak 6M) from 
three electrodes. Prior to the analysis, the SWCNT/Nafion 
film was cut along the inner circumference of the PTFE 
film with a 3 mm biopsy punch (Agar). After this cutting 
step, the PTFE film was removed leaving the active area of 
the electrode intact on the glass substrate for analysis.  
In order to optimize the accumulation time, 5 µM ox-
ycodone was measured with the Nafion/SWCNT elec-
trode with 0, 5, 10, and 15 min accumulation times. The 
stability of the electrode signal was determined by meas-
uring six sequential scans in 5 µM oxycodone. The elec-
trode was kept in PBS for 6.75 min between each scan. 
The relative standard deviation (RSD) was calculated for 
the oxycodone signal.  
A long-term stability test was conducted by measuring 
three electrodes in 5 µM of oxycodone in PBS at 1, 8, 15, 
and 22 days after coating. The RSD value was calculated 
for the average peak currents at each time point. The dif-
ference between the average peak currents at each time 
point with respect to the average peak current at time 
point 1 were calculated. The electrode-to-electrode repro-
ducibility was also determined by calculating the RSD 
value for the oxycodone signal from the three electrodes 
measured at time point 1. All RSD values were calculated 
from peak current values without background subtrac-
tion.  
2.5. Detection of oxycodone and metabolites 
Oxycodone hydrochloride powder and noroxycodone 
hydrochloride powder were purchased from TRC, Canada. 
In addition, oxymorphone hydrochloride was received 
from Professor Jari Yli-Kauhaluoma, synthesized at the 
University of Helsinki. The purity of oxymorphone was 
checked with mass spectrometer and found to be 77%. 
The measurements with oxymorphone have been added 
here as tentative results and are discussed as such, since 
further studies with pure oxymorphone should be con-
ducted for more detailed analysis. 
For the measurements with oxycodone, noroxycodone 
and oxymorphone, the analytes were measured first with 
both plain and Nafion coated SWCNT electrodes in 10 µM 
concentration. This was done to determine the oxidizing 
functional groups in the molecules and to assign them to 
corresponding oxidation peaks as well as to compare the 
electrochemical behavior of the analytes on the two elec-
trode types.  
The concentration series for oxycodone were measured 
with 0.5, 1, 2.5, 5, 7.5, and 10 µM with Nafion/SWCNT. The 
analyte was injected with a pipette into the 50 mL elec-
trochemical cell from a 1 mM stock solution. After each 
injection, the solution was mixed slightly with the pipette 
for 30 s and the measurement was started after 5 min ac-
cumulation time. Four electrodes were measured and 
were kept in PBS between the measurements. The linear 
range was plotted by taking the average of the peak cur-
rents for each electrode at each concentration point, the 
standard deviations as error bars. The LOD value was 
calculated with the formula LOD = 3.3 x 𝜎𝜎/s, where 𝜎𝜎 is 
the standard deviation of three consecutive background 
currents in µA (at the oxidation potential of oxycodone 
and without background correction) and s is the sensitivi-
ty of the electrode (µA/µM). The value was calculated as 
the average of four electrodes.  
To assess the capability of the electrodes to selectively 
detect oxycodone in the presence of the metabolites, all 
analytes were measured in relevant concentration ratios 
based on the average plasma concentrations given in5 and 
discussed in Section 1. The percentages of the metabolites 
were rounded up slightly and adjusted to a 5 µM oxyco-
done reference concentration. Thus, 5 µM oxycodone, 
3.75 µM noroxycodone and 250 nM oxymorphone were 
measured separately with both plain and Nafion coated 
SWCNT electrodes. The robustness of the electrodes was 
further assessed by measuring 5 µM oxycodone first alone 
and then 5 µM oxycodone in the presence of 3.75 µM no-
roxycodone and 250 nM oxymorphone. 
3. Results and discussion 
3.1. Characterization of SWCNT network 
The SWCNT networks from the same batch have been 
extensively characterized in our previous work by Raman 
spectroscopy, UV-Vis and X-ray-photoelectron microsco-
py (XPS) as well as TEM and XAS17. Briefly, in Raman 
spectroscopy analysis, the low Id/Ig ratio of 0.102 ± 0.003 
confirmed the presence of low amount of amorphous car-
bon and a small number of defects. The results also 
showed radial breathing modes corresponding to SWCNT 
diameters in the range of 1.2 - 2.1 nm, whereas a mean 
diameter of 2.1 nm was found with UV-Vis analysis. The 
XPS survey found 71.7 ± 0.2 at-% carbon, 8.7 ± 0.2 at-% 
oxygen and 0.1 ± 0.01 at-% iron as well as 19.5 ± 0.3 at-% 
Si. From these elements, Si and most of the oxygen are 
likely due to the partially exposed Si wafer with native 
oxide.  
Fig. 2A shows a TEM image from the SWCNT networks 
prepared in this work. In the HRTEM micrograph in Fig. 
2B, both individual and bundled SWCNT can be seen as 
well as typical catalyst particles encapsulated in a few 




Figure 2. Characterization of the SWCNT network. A) TEM image and B) HRTEM image of the SWCNT network. C) C1s D) O1s 
and E) Fe2p XAS spectra of the SWCNT.  
The surface chemistry of the SWCNT network was also 
further studied with XAS and peaks assigned according to 
extensive literature survey23–33. Figs. 2C, 2D and 2E show 
the XAS spectra for the C1s, O1s and Fe2p of the SWCNT, 
respectively. The C1s spectrum indicates highly sp2 bound 
carbon (sp2 pi* @ 285.5 eV) with a clear long range order 
(exciton @ 291.9 eV) and a relatively small oxygen surface 
loading, consistent with EDS analysis of previous work17. 
However, the C1s spectra also shows peaks likely attribut-
ed to ketone/aldehyde and carboxyl groups. In Fig. 2D, 
the contributions of C-O bonds and possible oxidized Fe 
is heavily convoluted by the partially exposed native oxide 
of Si in the O1s spectrum. Nevertheless, the spectrum 
suggests the presence of aldehyde, ketone and carboxyl 
functional groups on the SWCNT, as seen in17. The Fe2p 
spectrum shown in Fig. 2E also closely matches that of 
previous work, where the iron is expected to be bonded to  
carbon and oxygen (indicating presence of a mix of iron 
carbide34 and iron oxide seen as the higher energy peaks 
of the Fe2p LII and LIII spectra) and metallic iron (as the 
lower energy peaks of the Fe2p LII and LIII spectra). The 
results of the characterization from the previous and this 
work are summarized in Table 1. 
3.2. Characterization of Nafion/SWCNT electrode 
The thickness of the 2.5% dip coated Nafion membrane 
measured with profilometry was found to be the thickest 
in the center and thinnest near the edges of the PTFE 
film. The thickness in the center was 980 ± 48 nm and 
around 200 nm close to the cut edge. 
Extensive electrochemical characterization of Nafi-
on/SWCNT electrodes has been provided in16 and the 
behavior of Nafion studied in20. It has been shown that 
Nafion selectively lets through and enriches positively 
charged molecules while effectively blocking molecules 
with negative charge. In addition, Nafion significantly 
reduces the matrix effects in biological samples, thus ena-
bling direct detection of analytes in untreated real sam-
ples.   
For the oxycodone measurements, the concentration of 
2.5% Nafion was selected as the most suitable. With 2.5% 
Nafion, a higher sensitivity towards oxycodone was found 
compared to 5% (Fig. 3A). A 5 min accumulation time was 
found to be sufficient for achieving a clear signal for ox-
ycodone without compromising the fast nature of the 
measurement (Fig. 3B).  
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Table 1.  Summary of characterization results of this and previous work17. 
Sheet 
resistance 
Raman Id/Ig UV-Vis XPS EDS XAS 
88 Ω/sq 
 




C 71.7 ± 0.2  
O 8.7 ± 0.2 
Si* 19.5 ± 0.3 
Fe 0.1 ± 0.01 
Catalyst par-
ticles:  




Highly sp2 bound car-




carboxyl peaks detected 
 
Iron particles, iron car-
bide and iron oxide 
*Most of the detected oxygen and all silicon from the native oxide of the silicon wafer substrate 
 
Figure 3. Characterization of the Nafion/SWCNT electrode. A) Nafion concentration. 5 µM oxycodone with SWCNT with 2.5% 
Nafion and 5% Nafion. B) Accumulation time. 5 µM oxycodone measured with SWCNT 2.5% Nafion with accumulation times 0, 
5, 10 & 15 min.  
3.3. Electrochemical behavior of oxycodone and metab-
olites  
Fig. 4 shows the DPV curves for 10 µM oxycodone, no-
roxycodone and oxymorphone measured with a plain 
SWCNT electrode (A) and Nafion/SWCNT (B). The color 
bars highlight the oxidation peaks tentatively assigned to 
two different functional groups, also indicated with corre-
sponding colored circles in the chemical structures of 
oxycodone and the metabolites. Interestingly, although 
these analytes only differ from each other by one func-
tional group, both electrode types give different responses 
to each molecule.  
When measured without the Nafion coating, several ox-
idation peaks can be seen for each analyte. The first peak 
around 0.5 V is visible for oxymorphone but not for ox-
ycodone or noroxycodone. Since the only functional 
group that is found in oxymorphone but is lacking from 
oxycodone and noroxycodone is the phenol, this oxida-
tion peak can most probably be attributed to this group. 
In fact, we have seen this peak at a lower positive poten-
tial in our previous work with morphine16 and it has also 
been assigned to a similar phenol group in morphine by 
Garrido et al.13. 
Similarly, the second peak at 0.75 V is common to ox-
ycodone and oxymorphone but is not seen for noroxyco-
done, making the tertiary amine a probable source for 
this peak. The third peak, on the other hand, is well de-
fined at about 1.0 V for all three molecules, which sug-
gests that it could be due to further oxidation of the sec-
ondary amine. It has been shown in several studies that a 
tertiary amine frequently gives two separate oxidation 
peaks on carbon based electrodes12,16,17,35,36. However, 
based on these voltammograms, it is also possible that the 
third peak could be due to oxidation of the hydroxyl 
group in the amine ring12. Moreover, Garrido et al.37 have 
also assigned an oxidation peak for codeine at higher po-
tentials for the methoxy group which is also present in 
both oxycodone and noroxycodone.  
Thus, due to the complex nature of the oxidation pro-
cesses of oxycodone, it is not possible to make definite 
conclusions only based on voltammetric measurements 




Figure 4. Suggested electrochemical behavior of oxycodone and metabolites. 10 µM oxycodone (blue), 10 µM noroxycodone 
(green), and 10 µM oxymorphone (red) measured with A) a plain SWCNT electrode with no accumulation time and B) a Nafi-
on/SWCNT electrode with 5 min accumulation time. The color bars highlight the oxidation peaks, tentatively assigned to two 




Figure 5. Concentration series for oxycodone. A) Oxycodone with concentrations 0.5, 1, 2.5, 5, 7.5, & 10 µM with accumulation 
time 5 min and B) the average oxidation peak currents as a function of oxycodone concentration. Error bars show the standard 
deviations of the peak currents (n = 4). 
assignments, further experiments involving collecting 
reaction products should be done. 
When Nafion is applied onto the electrode, the current 
response changes significantly. The peak for the phenol 
group is clearly enhanced and shifted by about 50 mV to a 
more positive potential. The other two peaks are similarly 
shifted, but with about 200 mV.  
Based on this data, it seems that the order of the peaks is 
preserved also when using Nafion, since the middle peak 




Figure 6. Stability of the sensor structure. A) Electrode signal stability. 5 µM oxycodone measured with one SWCNT 2.5% Nafion 
6 times in a row. B) Long-time stability. 3 electrodes measured in 5 µM oxycodone after storing for 1, 8, 15 and 22 days after coat-
ing. Data shows the differences in the average values in the oxycodone peak current relative to day 1 in percentages as the func-
tion of days after coating. 
 
Figure 7. Oxycodone & metabolites without and with 2.5% Nafion. 5 µM oxycodone (blue), 3.75 µM noroxycodone (green) and 
250 nM oxymorphone (red) without Nafion (A) and with Nafion (B). 5 µM oxycodone (blue) and 5 µM oxycodone in the pres-
ence of the two metabolites, 3.75 µM noroxycodone and 250 nM oxymorphone (black dash), without Nafion (C) and with Nafion 
(D).   
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be well-defined only for oxycodone and oxymorphone 
and not for noroxycodone.  
We have previously seen that with this material combi-
nation, the addition of Nafion either blocks or shifts the 
oxidation signal from the tertiary amine in codeine-like 
molecules16. Although the results shown in Fig. 4B are not 
conclusive, they would suggest that Nafion is indeed 
shifting the oxidation peaks related to both amine and 
hydroxyl groups. This might be purely due to a mass 
transfer effect introduced by the Nafion layer. However, it  
is also possible that the sulfonic groups of Nafion some-
how interact or even react with some of the oxidizing 
groups in these molecules, thus altering their electro-
chemical behavior. In pH 7.4, the amine groups in the 
molecules are protonated and all three molecules are 
mainly in their cationic form (the pKa-values for the 
amine groups being about 8.8, 9.5 and 8.2 for oxycodone, 
noroxycodone and oxymorphone, respectively). Thus, it is 
likely that these cations interact with the sulfonic groups 
in Nafion also contributing to the enrichment behavior 
seen in Fig. 3B. However, confirming the exact mecha-
nisms of these interactions would require thorough inves-
tigations that are out of the scope of this paper. 
3.4. Concentration series for oxycodone  
The results from the oxycodone concentration series 
are shown in Fig. 5. In Fig. 5A, the average peak currents 
(n = 4) are plotted against potential and Fig. 5B shows the 
average peak currents as a function of concentration. The 
error bars show the standard deviation between elec-
trodes (n = 4). The linear range for oxycodone was 0.5 - 10 
µM and the limit of detection 85 nM. 
3.5. Stability of sensor structure 
From the signal stability study, the RSD for the 5 µM 
oxycodone signal was found to be 2.3% (Fig. 6A). For the 
electrode reproducibility, the RSD value for three elec-
trodes at time point 1 was 10%. However, the electrodes 
seemed to be stabilized over time, since the RSD value 
was decreased down to 3.8% by the day 22 after coating. 
The long-term stability of the electrodes was also found to 
be noticeably high, the RSD for the average peak currents 
between each time point being only 2.6%. Fig. 6B shows 
the differences of the average values in the oxycodone 
peak current relative to day 1 in percentages as the func-
tion of days after coating. These results are quite satisfac-
tory, especially considering the complex behavior of Nafi-
on in aqueous solutions.  
3.6. Simultaneous detection of oxycodone and metabo-
lites  
The DPV curves for 5 µM oxycodone, 3.75 µM no-
roxycodone and 250 nM oxymorphone are shown in Fig. 7 
measured separately with an electrode without (A) and 
with Nafion (B). Based on these measurements, it would 
seem that both electrode types would be able to selective-
ly detect oxycodone in the presence of its two metabolites 
(3.75 µM noroxycodone and 250 nM oxymorphone). In 
fact, this assumption is confirmed in Figs. 7C and 7D, 
where oxycodone is first measured alone and then simul-
taneously with the two metabolites with plain SWCNT 
(C) and Nafion/SWCNT (D).  
As can be seen from Figs. 7A and 7B, it could be argued 
that when applying the electrode in real patient samples, 
oxycodone could be detected in the presence of the two 
metabolites even without the Nafion. The clinically rele-
vant concentrations of oxycodone are typically well below 
5 µM; for example, Lalovic et al. found the average peak 
plasma concentration of oxycodone to be around 0.12 µM 
after a single 15-mg oral dose5. Thus, in most clinical situ-
ations, it is likely that the concentrations of oxycodone 
metabolites are below the detection limit of the electrode 
presented in this paper. However, the addition of Nafion 
clearly increases the oxidation signal for oxycodone and 
thus improves the detection limit of the sensor. In addi-
tion, Nafion gives significant advantages when measuring 
in real samples as it filters out interferents and greatly 
reduces the matrix effects, enabling direct measurements 
in unprocessed biological samples15,16.  
Conclusions 
We have developed a disposable, mass-producible 
Nafion coated single-walled carbon nanotube sensor and 
demonstrated, for the first time, selective detection of 
oxycodone in the presence of its two major metabolites. 
The electrochemical behavior of oxycodone, noroxyco-
done and oxymorphone was compared between a plain 
and a Nafion coated SWCNT electrode. The Nafion mem-
brane was seen to significantly affect the oxidation of 
these three analytes. With the Nafion/SWCNT electrode, 
a limit of detection of 85 nM and a linear range of 0.5 - 10 
µM were achieved for oxycodone in buffer solution. In 
addition, both plain and Nafion coated SWCNT elec-
trodes were found to be able to detect oxycodone in the 
presence of its two metabolites noroxycodone and oxy-
morphone. However, the use of the Nafion membrane 
greatly enhanced the oxidation current for oxycodone, 
making the Nafion/SWCNT hybrid a preferable choice for 
detection of oxycodone in real samples. Thus, the Nafi-
on/SWCNT electrode has real potential to be applied in a 
point-of-care device aiding healthcare professionals in 
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